BisphosphonatesREID, Ian R.Skeletal radiology. 2007, Vol 36, Num 8, pp 711-714, issn 0364-2348, 4 p.Article

Profiling the safety and tolerability of bisphosphonates : IbandronateBODY, Jean-Jacques; DIEL, Ingo; BELL, Richard et al.Seminars in oncology. 2004, Vol 31, Num 5, pp 73-78, issn 0093-7754, 6 p., SUP10Article

Bisphosphonate actions : Physical chemistry revisitedPAPAPOULOS, Socrates E.Bone (New York, NY). 2006, Vol 38, Num 5, pp 613-616, issn 8756-3282, 4 p.Article

Antitumor Effects and Anticancer Applications of BisphosphonatesMORGAN, Gareth; LIPTON, Allan.Seminars in oncology. 2010, Vol 37, Num 5, issn 0093-7754, S30-S40, SUP2Article

Molecular mechanisms of action of bisphosphonates : Current statusROELOFS, Anke J; THOMPSON, Keith; GORDON, Sharon et al.Clinical cancer research. 2006, Vol 12, Num 20, issn 1078-0432, 6222s-6230s, 2Conference Paper

The effects of bisphosphonates on osteoblasts in vitroNAIDU, Aparna; DECHOW, Paul C; SPEARS, Robert et al.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2008, Vol 106, Num 1, pp 5-13, issn 1079-2104, 9 p.Article

Osseointegration of cementless implants with different bisphosphonate regimensEBERHARDT, Christian; STUMPF, Ulla; BRANKAMP, Jochen et al.Clinical orthopaedics and related research. 2006, Num 447, pp 195-200, issn 0009-921X, 6 p.Article

Bisphosphonate-associated mandibular osteonecrosisCARNEIRO, E; VIBHUTE, P; MONTAZEM, A et al.American journal of neuroradiology. 2006, Vol 27, Num 5, pp 1096-1097, issn 0195-6108, 2 p.Article

Pharmaceutical care and community pharmacists' understanding of bisphosphonate dosing informationLI, W. W; KENDLER, D. L.Journal of clinical pharmacy and therapeutics (Print). 2004, Vol 29, Num 6, pp 531-536, issn 0269-4727, 6 p.Article

Les bisphosphonates = BisphosphonatesPETIT, T.La Lettre du sénologue. 2010, Num 48, issn 1289-2505, p. 29Conference Paper

Bisphosphonates and implants : An overviewASPENBERG, Per.Acta orthopaedica (Print). 2009, Vol 80, Num 1, pp 119-123, issn 1745-3674, 5 p.Article

Management of Bisphosphonate Treatment in Clinical PracticeAAPRO, Matti S.Seminars in oncology. 2007, Vol 34, Num 6, issn 0093-7754, S28-S32, SUP4Conference Paper

Long-term outcome of weekly bisphosphonates : OsteoporosisRIZZOLI, René.Clinical orthopaedics and related research. 2006, Num 443, pp 61-65, issn 0009-921X, 5 p.Article

Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial: Clinical articleNAGAHAMA, Ken; KANAYAMA, Masahiro; TOGAWA, Daisuke et al.Journal of neurosurgery. Spine. 2011, Vol 14, Num 4, pp 500-507, issn 1547-5654, 8 p.Article

A biocompatible method of decorporation : Bisphosphonate- modified magnetite nanoparticles to remove uranyl ions from bloodLING WANG; ZHIMOU YANG; JINHAO GAO et al.Journal of the American Chemical Society. 2006, Vol 128, Num 41, pp 13358-13359, issn 0002-7863, 2 p.Article

Targeting systemically administered proteins to bone by bisphosphonate conjugationULUDAG, Hasan; YANG, Jennifer.Biotechnology progress. 2002, Vol 18, Num 3, pp 604-611, issn 8756-7938, 8 p.Article

Safety Profile of Intravenous BisphosphonatesMEHROTRA, Bhoomi.Seminars in oncology. 2007, Vol 34, Num 6, issn 0093-7754, S24-S27, SUP4Conference Paper

Les bisphosphonates en oncologie : incertitudes et controverses en 2007 : Cancer = Bisphosphonates in oncology : update 2007ZAMAN, K; FAVET, L; SCHUSTERBAUER, C et al.Revue médicale suisse. 2007, Vol 3, Num 112, issn 1660-9379, 1317-1321 [4 p.]Article

Bone augmentation around and within porous implants by local bisphosphonate elution : The treatment of osteoarthritis of the hip 1920TANZER, Michael; KARABASZ, Dorota; KRYGIER, Jan J et al.Clinical orthopaedics and related research. 2005, Num 441, pp 30-39, issn 0009-921X, 10 p.Article

Serum 25-Hydroxyvitamin D Level and Acute-Phase Reaction Following Initial Intravenous BisphosphonateSRIVASTAVA, Tarak; HONGYING DAI; HANEY, Connie J et al.Journal of bone and mineral research (Print). 2011, Vol 26, Num 2, pp 437-438, issn 0884-0431, 2 p.Article

Bisphosphonates and osteonecrosis of the jaws : Science and rationaleGUTTA, Rajesh; LOUIS, Patrick J.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2007, Vol 104, Num 2, pp 186-193, issn 1079-2104, 8 p.Article

Imaging findings of bisphosphonate-associated osteonecrosis of the jawsPHAL, P. M; MYALL, R. W. T; ASSAEL, L. A et al.American journal of neuroradiology. 2007, Vol 28, Num 6, pp 1139-1145, issn 0195-6108, 7 p.Article

A time for perspective on bisphosphonatesASSAEL, Leon A.Journal of oral and maxillofacial surgery. 2006, Vol 64, Num 6, pp 877-879, issn 0278-2391, 3 p.Article

The inhibitory effect of bisphosphonates on glucocorticoid-induced RANKL expression in human cellsKOBAYASHI, A; HIRANO, F; MAKINO, I et al.Scandinavian journal of rheumatology. 2005, Vol 34, Num 6, pp 480-484, issn 0300-9742, 5 p.Article

Ostéoporose en pédiatrie : place des biphosphonatesMOULIN, P; GENNERO, I; TAUBER, M et al.Médecine & enfance. 2004, Vol 24, Num 10, pp 593-597, issn 0291-0233, 5 p.Article